(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
* Boris Johnson to decide on easing in lockdown measures
* AstraZeneca falls after withdrawing cancer drug use
* IAG gains after a liquidity raise
* FTSE 100 down 0.7%, FTSE 250 off 0.8% (Adds comment, updates prices)
By Shivani Kumaresan
Feb 22 (Reuters) - London's FTSE 100 fell on Monday as higher commodity prices sparked fears of a spike in inflation, while investors awaited Prime Minister Boris Johnson's plan for a phased easing of business restrictions.
The blue-chip FTSE 100 .FTSE fell 0.7%, led by declines in consumer staples and industrials stocks.
Johnson will plot a path out of COVID-19 lockdown on Monday in an effort to gradually reopen the battered $3 trillion economy, aided by one of the fastest vaccine rollouts in the world. inflation that's coming will be affecting the supply chain with a grid-locked type scenario where you can't get the goods you want," said Keith Temperton, a sales trader at Forte Securities.
The FTSE 100 has recovered nearly 35% from its March 2020 lows and is nearly 13% away from its highest level last year, thanks to record stimulus measures and massive vaccine rollouts.
The mid-cap index .FTMC fell 0.8%, with G4S (CSE: G4S ) Plc GFS.L being the biggest drag on the index after Canada's GardaWorld said it would not raise its offer, appearing to leave the way clear for the higher bid lodged by rival Allied Universal to succeed. Airways-owner IAG ICAG.L rose 1.4% after it said it raised total liquidity by 2.45 billion pounds ($3.4 billion) by reaching final agreement for a 2-billion-pound loan and through a deal to defer 450 million pounds of pension deficit contributions. operator Mitchells & Butlers MAB.L rose 9.7% despite reporting a plunge in sales as all its sites were forced shut under the latest lockdown. AstraZeneca AZN.L fell 0.3% after voluntarily withdrawing the use of its cancer drug Imfinzi to treat advanced bladder cancer in the United States after it failed to meet post-approval requirements.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.